MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字SJ20200007

January 7, 2025

S20200007

Drug Information

阿达木单抗注射液

修美乐

注射剂

20mg/0.2ml

生物制品

January 7, 2025

January 6, 2030

Company Information

Applicant Company

Knollstrasse, 67061 Ludwigshafen, Germany

Manufacturing Company

vetter pharma-fertigung gmbh & co.kg

Schützenstrasse 87 and 99-101, 88212 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath